Recombinant human SLC19A3 protein; Source: E. coli derived, PGEX-4T; Tag: GST; Domain: 188-315 aa of BC032014
Conjugate
Unconjugated
Applications
Application Notes
WB: 1:500-1:2000 IP: 0.5-4.0 μg for 1.0-3.0 mg of total protein lysate
General Notes
This product (Catalog No. DPABH-25853) is a rabbit-derived polyclonal antibody raised against human SLC19A3, targeting the amino acid region 188–315 of the protein. This antibody exhibits cross-reactivity with Human SLC19A3 from mouse and rat. It has been affinity purified by Protein A. SLC19A3 is a member of the reduced folate family of micronutrient transporter genes. It is a ubiquitously expressed transmembrane thiamine transporter that lacks folate transport activity yet mediates high affinity thiamine uptake propably via a proton anti-port mechanism. Mutations in this gene cause biotin-responsive basal ganglia disease (BBGD); a recessive disorder manifested in childhood that progresses to chronic encephalopathy, dystonia, quadriparesis, and death if untreated. Patients with BBGD have bilateral necrosis in the head of the caudate nucleus and in the putamen. Mutations in this gene also cause a Wernickes-like encephalopathy. DPABH-25853 is suitable for use in Western blot (WB) (1:500–1:2,000), IP (0.5-4.0 μg for 1.0-3.0 mg of total protein lysate) applications. DPABH-25853 is supplied as a liquid formulation in PBS with 0.02% sodium azide and 50% glycerol, pH 7.3. For long-term storage, keep at −20 °C. For short-term use, store at 2–8 °C. Avoid repeated freeze–thaw cycles to maintain antibody integrity and performance.
My Review for Rabbit Anti-Human SLC19A3 (a.a. 188-315) Polyclonal antibody
Creative Diagnostics products are for RESEARCH USE ONLY, please make sure your review is research based.
Required fields are marked with *
Terms and conditions:
We will select high-quality review customers and offer a $30 coupon for your next purchase.
All product reviews must be submitted in the English language.
Creative Diagnostics will not share any personal information of applicants, and all information will be treated with strict confidentiality and will not be sold or disclosed to a third party.